Dr. Maureen Merrifield is Vice President of Regulatory and Clinical Affairs at Pharmatech Associates, Dr. Merrifield is responsible for oversight and management of the regulatory affairs division including nonclinical, clinical and CMC regulatory strategies, submissions and management. Dr. Merrifield has over 13 years of experience in the biotechnology and pharmaceutical industry, and has been working in regulatory affairs, quality assurance, regulatory compliance and operations activities since 2006. She has supported early and late-stage drug development in multiple therapeutic areas including cell/gene therapy, peptides, monoclonal antibodies, vaccines, small molecule, blood/tissue therapy products and combination products.
Dr. Merrifield has held leadership positions at both large and small life sciences organizations including CROs including, Bellicum Pharmaceuticals, Sanofi, GlaxoSmithKline and Clinipace and has prepared and filed numerous regulatory submissions with both domestic and international regulatory authorities. Her expertise in regulatory research and surveillance, has been instrumental in developing regulatory pathways to market for unique and complex investigational products.
Dr. Merrifield holds a Ph.D. in Chemistry from Western University in Ontario, Canada and an Bachelor of Science with Honors in Chemistry from Western University in Ontario, Canada.